IRIS Accounts Production v23.3.1.45 12448978 Board of Directors 1.3.22 28.2.23 28.2.23 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh124489782022-02-28124489782023-02-28124489782022-03-012023-02-28124489782021-02-28124489782021-03-012022-02-28124489782022-02-2812448978ns10:Originalns15:EnglandWales2022-03-012023-02-2812448978ns14:PoundSterlingns10:Original2022-03-012023-02-2812448978ns10:Originalns10:Director12022-03-012023-02-2812448978ns10:Original2022-03-012023-02-2812448978ns10:Original2023-02-2812448978ns10:Originalns10:PrivateLimitedCompanyLtd2022-03-012023-02-2812448978ns10:Originalns10:SmallEntities2022-03-012023-02-2812448978ns10:Originalns10:AuditExempt-NoAccountantsReport2022-03-012023-02-2812448978ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-03-012023-02-2812448978ns10:SmallCompaniesRegimeForAccountsns10:Original2022-03-012023-02-2812448978ns10:Originalns10:FullAccounts2022-03-012023-02-2812448978ns10:Originalns10:OrdinaryShareClass12022-03-012023-02-2812448978ns10:Originalns10:OrdinaryShareClass22022-03-012023-02-2812448978ns10:Original2022-02-2812448978ns10:Originalns5:CurrentFinancialInstruments2023-02-2812448978ns10:Originalns5:CurrentFinancialInstruments2022-02-2812448978ns5:ShareCapitalns10:Original2023-02-2812448978ns5:ShareCapitalns10:Original2022-02-2812448978ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-02-2812448978ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-02-2812448978ns10:Originalns10:RegisteredOffice2022-03-012023-02-2812448978ns10:Originalns5:ComputerEquipment2022-03-012023-02-2812448978ns10:Original2021-03-012022-02-2812448978ns10:Originalns5:ComputerEquipment2022-02-2812448978ns10:Originalns5:ComputerEquipment2023-02-2812448978ns10:Originalns5:ComputerEquipment2022-02-2812448978ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-02-2812448978ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-02-2812448978ns5:AcceleratedTaxDepreciationDeferredTaxns10:Original2023-02-2812448978ns5:AcceleratedTaxDepreciationDeferredTaxns10:Original2022-02-2812448978ns10:Originalns5:DeferredTaxation2022-03-012023-02-2812448978ns10:Originalns5:DeferredTaxation2023-02-2812448978ns10:Originalns10:OrdinaryShareClass12023-02-2812448978ns10:Originalns10:OrdinaryShareClass22023-02-28
REGISTERED NUMBER: 12448978 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

28 FEBRUARY 2023

FOR

PAGE MEDICAL AND SURGICAL LIMITED

PAGE MEDICAL AND SURGICAL LIMITED (REGISTERED NUMBER: 12448978)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023










Page

Balance Sheet 1

Notes to the Financial Statements 3


PAGE MEDICAL AND SURGICAL LIMITED (REGISTERED NUMBER: 12448978)

BALANCE SHEET
28 FEBRUARY 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 1,732 2,398

CURRENT ASSETS
Debtors 6 11,058 11,325
Cash at bank 618 607
11,676 11,932
CREDITORS
Amounts falling due within one year 7 7,310 16,826
NET CURRENT ASSETS/(LIABILITIES) 4,366 (4,894 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

6,098

(2,496

)

PROVISIONS FOR LIABILITIES 8 329 -
NET ASSETS/(LIABILITIES) 5,769 (2,496 )

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 5,669 (2,596 )
SHAREHOLDERS' FUNDS 5,769 (2,496 )

PAGE MEDICAL AND SURGICAL LIMITED (REGISTERED NUMBER: 12448978)

BALANCE SHEET - continued
28 FEBRUARY 2023


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 November 2023 and were signed on its behalf by:





Mr P R J Page - Director


PAGE MEDICAL AND SURGICAL LIMITED (REGISTERED NUMBER: 12448978)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023


1. STATUTORY INFORMATION

Page Medical and Surgical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12448978

Registered office: 53 Gildredge Road
Eastbourne
East Sussex
BN21 4SF

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
The turnover shown in the profit and loss account represents amounts receivable for services provided during the year.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 25% on cost

All fixed assets are initially recorded at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


PAGE MEDICAL AND SURGICAL LIMITED (REGISTERED NUMBER: 12448978)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2023


3. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

PAGE MEDICAL AND SURGICAL LIMITED (REGISTERED NUMBER: 12448978)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2023


5. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 March 2022 3,198
Additions 178
At 28 February 2023 3,376
DEPRECIATION
At 1 March 2022 800
Charge for year 844
At 28 February 2023 1,644
NET BOOK VALUE
At 28 February 2023 1,732
At 28 February 2022 2,398

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 9,850 7,400
Provision for doubtful debts - (120 )
Prepayments and accrued income 1,208 4,045
11,058 11,325

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors - 30
Corporation tax 820 -
Directors' current account 5,321 15,841
Accruals and deferred income 1,169 955
7,310 16,826

8. PROVISIONS FOR LIABILITIES
2023 2022
£    £   
Deferred tax
Accelerated capital allowances 329 -

PAGE MEDICAL AND SURGICAL LIMITED (REGISTERED NUMBER: 12448978)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2023


8. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Provided during year 329
Balance at 28 February 2023 329

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
50 Ordinary A £1 50 50
50 Ordinary B £1 50 50
100 100